Zhuhai Trinomab Pharmaceutical Co., Ltd. (SHA:688806)
China · Delayed Price · Currency is CNY 23.04
-1.18 (-4.87%)
At close: Sep 4, 2026
SHA:688806 Revenue
Zhuhai Trinomab Pharmaceutical had revenue of 51.31M CNY in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to 116.93M. In the year 2025, Zhuhai Trinomab Pharmaceutical had annual revenue of 51.22M with 240.23% growth.
Revenue (ttm)
116.93M
Revenue Growth
+240.23%
P/S Ratio
90.75
Revenue / Employee
n/a
Employees
843
Market Cap
10.61B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 51.22M | 36.17M | 240.23% |
| Dec 31, 2024 | 15.06M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 4.34M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.